Production (Stage)
NLS Pharmaceutics AG
NLSP
$2.30
$0.2210.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 201.27% | 0.00% | -38.42% | 0.00% |
| Total Receivables | 0.00% | 454.94% | 0.00% | 130.77% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -84.73% | 0.00% | 330.87% | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -75.06% | 0.00% | -68.17% | 0.00% |
| Total Current Assets | 0.00% | 86.63% | 0.00% | -34.59% | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | 86.63% | 0.00% | -34.59% | 0.00% |
| Net Property, Plant & Equipment | 0.00% | 630.00% | 0.00% | -85.07% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | 0.00% |
| Total Assets | 0.00% | 87.11% | 0.00% | -35.37% | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | -88.76% | 0.00% | -1.06% | 0.00% |
| Total Accrued Expenses | 0.00% | -78.08% | 0.00% | -7.76% | 0.00% |
| Short-term Debt | -- | -- | 0.00% | 4.89% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 0.00% |
| Total Other Current Liabilities | -- | -- | -- | -- | 0.00% |
| Total Current Liabilities | 0.00% | -89.29% | 0.00% | -2.54% | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | -89.29% | 0.00% | -2.54% | 0.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 0.00% | 4.89% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | -0.62% | 0.00% |
| Total Liabilities | 0.00% | -92.10% | 0.00% | -2.05% | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 15.60% | 0.00% | 2.33% | 0.00% |
| Retained Earnings | 0.00% | -2.79% | 0.00% | -2.89% | 0.00% |
| Treasury Stock & Other | 0.00% | 2,492.86% | 0.00% | 102.66% | 0.00% |
| Total Common Equity | 0.00% | 85.60% | 0.00% | -4.92% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | 85.60% | 0.00% | -4.92% | 0.00% |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 115.17% | 0.00% | -4.92% | 0.00% |
|
|
|||||